Xue Zhang, Wen-Jie Yin, Ai-Li Zhang, Xiao-Xiao Zhang, Li-Juan Ding, Jiao Zhang, . . . Jie-Ping Yan. (2024). Meta-analysis of efficacy and safety of pembrolizumab for the treatment of advanced or recurrent cervical cancer. Taylor & Francis Group.
Chicago Style (17th ed.) CitationXue Zhang, Wen-Jie Yin, Ai-Li Zhang, Xiao-Xiao Zhang, Li-Juan Ding, Jiao Zhang, Shu-Ting He, and Jie-Ping Yan. Meta-analysis of Efficacy and Safety of Pembrolizumab for the Treatment of Advanced or Recurrent Cervical Cancer. Taylor & Francis Group, 2024.
MLA (9th ed.) CitationXue Zhang, et al. Meta-analysis of Efficacy and Safety of Pembrolizumab for the Treatment of Advanced or Recurrent Cervical Cancer. Taylor & Francis Group, 2024.
Warning: These citations may not always be 100% accurate.